CTXR
Citius Pharmaceuticals
$0.52
−$0.00 (−0.58%)Jul 27, 2026
Key metrics
The numbers that frame CTXR today
- Market cap
- $14.19M
- P/E (TTM)
- -0.3
- EV / FCF
- -0.3
- Gross margin
- 80.1%
- EV / Sales
- 1.8
- ROIC
- -62.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.47
- 52wk High
- $2.19
Growth
Revenue and earnings trend for CTXR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTXR
Is Citius Pharmaceuticals a good buy?
No. Citius Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Citius Pharmaceuticals is selling at a very high price.
What is the market capitalization of CTXR?
Citius Pharmaceuticals's market capitalization is $14.19M.
What is the P/E ratio for CTXR stock?
Citius Pharmaceuticals's current P/E ratio is -0.3.
What is the 52-week high for CTXR stock?
The 52-week high for Citius Pharmaceuticals is $2.19. The current close of $0.52 is 76.4% below that high.
What is the 52-week low for CTXR stock?
The 52-week low for Citius Pharmaceuticals is $0.47. The current close of $0.52 is 10.2% above that low.
Does CTXR stock pay dividends?
Citius Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTXR?
Citius Pharmaceuticals's Debt / Equity ratio is 0.01.